a 3-month clinical trial comparing oxybutynin XL 10 mg/day with tolterodine IR 4 mg/day. The daily costs of oxybutynin XL and tolterodine IR were £0.82 and £1.04, respectively. These data and ...
Kaplan et al. investigated the efficacy and safety of the antimuscarinic tolterodine extended release (ER), the α 1-receptor antagonist tamsulosin, and a combination of both, in men with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback